Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TF002 (Miltefosine) in Cutaneous Mastocytosis
NCT00457288Phase 2Completed
- Sponsor
- JADO Technologies GmbH
- Start
- Apr 2007
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miltefosine in cutaneous mastocytosis (CM), systemic mastocytosis (SM), sponsored by JADO Technologies GmbH. Started Apr 2007; status: completed.
02
Drugs
miltefosine
03
Conditions
cutaneous mastocytosis (CM)systemic mastocytosis (SM)
Beyond the preview
Go deeper on NCT00457288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00457288.